Pila Pharma AB Cash Flow-to-Debt Ratio
Pila Pharma AB cash flow-to-debt ratio. Pila Pharma AB (PILA) has a Cash Flow-to-Debt Ratio of -0.98x as of December 2025, meaning its operating cash flow of Skr-1.41 Million could theoretically repay -1% of its total liabilities (Skr1.43 Million) in one year. See Pila Pharma AB (PILA) financial flexibility to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Pila Pharma AB (2018–2025)
Cash flow-to-debt ratio of Pila Pharma AB from 2018 to 2025. Historical debt coverage capacity for Pila Pharma AB across 8 annual periods. Check PILA cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Pila Pharma AB Cash Flow-to-Debt Ratio by Year (2018–2025)
Pila Pharma AB cash flow-to-debt ratio by year from 2018 to 2025. Year-by-year debt coverage analysis for Pila Pharma AB. For the full cash flow conversion analysis, see Pila Pharma AB (PILA) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -6.41x | Skr-9.19 Million | Skr1.43 Million | ▲ +21.1% |
| 2024 | -8.12x | Skr-7.82 Million | Skr963.00K | ▼ -200.3% |
| 2023 | -2.71x | Skr-4.85 Million | Skr1.79 Million | ▲ +59.6% |
| 2022 | -6.70x | Skr-9.09 Million | Skr1.36 Million | ▼ -8.4% |
| 2021 | -6.18x | Skr-9.36 Million | Skr1.51 Million | ▼ -501.6% |
| 2020 | -1.03x | Skr-2.00 Million | Skr1.95 Million | ▲ +90.1% |
| 2019 | -10.36x | Skr-5.02 Million | Skr484.68K | ▼ -86.7% |
| 2018 | -5.55x | Skr-4.56 Million | Skr821.98K | — |